Bortezomib

Overview

Bortezomib is a proteasome inhibitor used as an anticancer drug for the treatment of multiple myeloma and certain types of lymphoma. It works by interrupting the proteasome pathway, leading to cellular apoptosis in cancer cells.

API suppliers (12)

Suppliers of Bortezomib backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• SHILPA PHARMA LIFESCIENCES LTD2 active DMF
• CTX LIFE SCIENCES PVT LTD1 active DMF
• Dr. Reddy's Laboratories Ltd.India1 active DMF
• Natco PharmaIndia1 active DMF
• TAPI NL BV1 active DMF
• TAPI NL BV1 active DMF
• APICORE US LLCUnited States1 active DMF
• Dr. Reddy's Laboratories Ltd.India1 active DMF
• SCINOPHARM TAIWAN LTD1 active DMF
• Zhejiang Hisun Pharmaceutical Co., Ltd.China
• Ono Pharmaceutical Co., Ltd.Japan
• Cipla USA, Inc.USA

Therapeutic areas